Evidence map›Paper›PMID 38258892›Full record

ArticleHealth policy and planning2024

Factors impacting sustained coverage in the context of donor transitions: experience from Sri Lanka.

Prasadini N Perera, Sarasi N Amarasinghe, Sachini H Fonseka, Nihal Abeysinghe, Ravindra P Rannan-Eliya

Open access · goldAbstract read
In one paragraph

Article in Health policy and planning, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Still rethinking external assistance for health.Health policy and planning · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Prasadini N PereraInstitute for Health Policy (IHP), 72, Park Street, Colombo 02, Sri Lanka.ORCID 0000-0001-7887-7564
Sarasi N AmarasingheInstitute for Health Policy (IHP), 72, Park Street, Colombo 02, Sri Lanka.
Sachini H FonsekaInstitute for Health Policy (IHP), 72, Park Street, Colombo 02, Sri Lanka.
Nihal AbeysingheInstitute for Research & Development, Battaramulla, Sri Lanka.
Ravindra P Rannan-EliyaInstitute for Health Policy (IHP), 72, Park Street, Colombo 02, Sri Lanka.
Institute of Policy Studies of Sri Lanka · LKInstitute for Research and Development · LKUniversity of Peradeniya · LK

Funding

Alliance for Alliance for Health Policy and Systems Research, WHO in collaboration with the WHO Department of Health Governance and Financing and UHC 2030 APW 202675851
6 · The paper itself

Abstract

Although not reliant on donor funding for health, the external assistance that Sri Lanka receives contributes to the improvement of the health system and health outcomes. In this study, we evaluated transition experiences of the expanded programme on immunization (EPI) that received Gavi funding to expand the vaccine portfolio and the Anti-Malaria Campaign (AMC) that received funding from the Global Fund for AIDS, Tuberculosis and Malaria to scale-up interventions to target and achieve malaria elimination. We assessed if EPI and AMC programmes were able to sustain coverage of previously donor-funded interventions post-transition and explain the facilitators and barriers that contribute to this. We used a mixed methods approach using quantitative data to assess coverage indicators and the financing mix of the health programmes and qualitative analysis guided by a framework informed by the Walt and Gilson policy triangle that brought together document review and in-depth interviews to identify facilitators and barriers to transition success. The EPI programme showed sustained coverage of Gavi-funded vaccines post-transition and the funding gap was bridged by mobilizing domestic financing facilitated by the Gavi co-financing mechanism, full integration within existing service delivery structures, well-established and favourable pharmaceutical procurement processes for the public sector and stewardship and financial advocacy by technically competent managers. Although the absence of indigenous cases of malaria since 2012 suggests overall programme success, the AMC showed mixed transition success in relation to its different programme components. Donor-supported programme components requiring mobilization of operational expenses, facilitated by early financial planning, were successfully transitioned (e.g. entomological and parasitological surveillance) given COVID-19-related constraints. Other key programme components, such as research, training, education and awareness that are dependent on non-operational expenses are lagging behind. Additionally, concerns of AMC's future financial sustainability within the current structure remain in the context of low malaria burden.

Indexed as

AntimalarialsCOVID-19MalariaEducational StatusHumansSri LankaAntimalarialsdevelopment assistance for healthDonor transitionsexternal assistanceimmunizationmalaria

Identifiers

PMID38258892
PMCPMC10805178
OpenAlexW4391145200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.